Clinicians who care for brain-injured patients and premature infants desire a bedside monitor of brain function. A decade ago, there was hope that optical imaging would be able to fill this role, as it combined fMRI\u27s ability to construct cortical maps with EEG\u27s portable, cap-based systems. However, early optical systems had poor imaging performance, and the momentum for the technique slowed. In our lab, we develop diffuse optical tomography: DOT), which is a more advanced method of performing optical imaging. My research has been to pioneer the in vivo use of DOT for advanced neuroimaging by: 1) quantifying the advantages of DOT through both in silico simulation and in vivo performance metrics,: 2) restoring confidence in the technique with the first retinotopic mapping of the visual cortex: a benchmark for fMRI and PET), and: 3) creating concepts and methods for the clinical translation of DOT. Hospitalized patients are unable to perform complicated neurological tasks, which has motivated us to develop the first DOT methods for resting-state brain mapping with functional connectivity. Finally, in collaboration with neonatologists, I have extended these methods with proof-of-principle imaging of brain-injured premature infants. This work establishes DOT\u27s improvements in imaging performance and readies it for multiple clinical and research roles
